000 01172 a2200337 4500
005 20250512195212.0
264 0 _c19810528
008 198105s 0 0 eng d
022 _a0022-3549
024 7 _a10.1002/jps.2600700224
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBlack, D B
245 0 0 _aRoutine quality evaluation of benzodiazepine drugs to USP-NF specifications.
_h[electronic resource]
260 _bJournal of pharmaceutical sciences
_cFeb 1981
300 _a208-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Anxiety Agents
_xanalysis
650 0 4 _aChlordiazepoxide
_xstandards
650 0 4 _aChromatography, Gas
650 0 4 _aDiazepam
_xstandards
650 0 4 _aFlurazepam
_xstandards
650 0 4 _aPharmacopoeias as Topic
650 0 4 _aQuality Control
650 0 4 _aTablets
650 0 4 _aUnited States
700 1 _aLawrence, R C
700 1 _aLovering, E G
700 1 _aWatson, J R
773 0 _tJournal of pharmaceutical sciences
_gvol. 70
_gno. 2
_gp. 208-11
856 4 0 _uhttps://doi.org/10.1002/jps.2600700224
_zAvailable from publisher's website
999 _c6110790
_d6110790